Reporters and news media writers can visit our page specifically cultivated for press contacts. The page features a list of LUGPA spokespeople.

Latest News

LUGPA's COVID-19 / Coronavirus Information Hub collects all the relevant resources, announcements and recommended reading about telemedicine, practice management, and events to help you during this pandemic.




LUGPA Leaders Published in NEJM
June 2, 2020 
LUGPA Past President Neal Shore, MD, and other LUGPA member co-authors had three trials published in the New England Journal of Medicine (NEJM) recently.

  • Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer (PROSPER trial)
  • Olaparib for Metastatic Castration-Resistant Prostate Cancer (PROfound trial)
  • Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer (HERO trial)

Mara R. Holton: Coronavirus Could Shut Down Independent Medical Practices Across Maryland and the Nation
May 24, 2020 
In a Capital Gazette op-ed, LUGPA Board member Mara Holton, MD writes: “What happens to patients and our healthcare system if independent physicians are unable to weather the storm and practices across the nation close? More patients will have no choice but to pay the higher costs seen within local hospital monopolies. Consolidation and care costs will continue increasing unabatedly. Protecting patients and the future of our healthcare system means protecting independent practices. Congress and insurers must step up their support or risk losing this vital part of America’s healthcare infrastructure. The implications of independent practices closing cannot be overstated as we face this crisis and consider the healthcare landscape of the future.”


How COVID-19 Imperiled Physician Practices, And How to Save Them
May 6, 2020 
RevCycle Intelligence has published an article that quotes LUGPA President, Dr. Harris several times and shares his insights and perspectives on the impact of COVID-19 on telehealth, revenue, and reimbursement for independent physicians and their practices.   



Physician groups 'struggling to survive' after COVID-19 — Will they succumb to hospital buyouts? 4 thoughts from Dr. Richard Harris
May 1, 2020 
LUGPA President Richard Harris, MD, a Melrose Park, Ill.-based urology specialist, shared his thoughts with Becker's ASC Review on how independent practices will fare — and what can be done to help them survive — after the crisis subsides.


Can Independent Practices Survive This Crisis Without Government Support? 
April 23, 2020
With in-office visits declining by 50 percent or more, many independent medical practices may need outside help to survive. Medical Economics interviewed LUGPA board member Mara R. Holton, MD, who has been active on the Health Policy and Political Affairs and LUGPA Forward committees.  



From house calls to drive-thru visits, independent physicians adapt amid COVID-19 crisis.
April 14, 2020 
LUGPA President Dr. Harris is quoted in this ABC news article regarding the COVID-19 challenges facing independent physicians. 


American Patients Vastly Prefer Healthcare Price Transparency, According to New Survey

April 3, 2020 
Medical Economics
 published an article on LUGPA's price transparency survey. The article shares the findings from the survey, and includes quotes from LUGPA President Dr. Harris. Additionally, the same article also appeared in Physicians Practice.  


New Survey Finds 91% of Americans Want Healthcare Price Transparency
April 1, 2020
LUGPA released the results of a new survey of American consumers that found an overwhelming majority of Americans support price transparency in healthcare. When surveyed, 91% of the 1,342 respondents said they believe hospitals and healthcare facilities should be required to publicly disclose the costs of their services. What’s more, 66% of respondents believe price transparency will improve healthcare.


LUGPA Leaders Convene Panel to Optimize Role of ADT in Advanced Prostate Cancer
March 23, 2020
LUGPA is pleased to announce the publication of "Optimizing the Role of Androgen Deprivation Therapy in Advanced Prostate Cancer: Challenges Beyond the Guidelines" in The Prostate (Prostate. 2020 Mar 4. doi: 10.1002/pros.23967),  Neal D. Shore, MD, et al.  Dr. Shore, Past President of LUGPA (2016-2018), led a 14- member expert panel of LUGPA and Academic urologists and medical oncologists, which discussed key questions on the use of ADT in clinical practice – addressing questions that are not always answered by prior published guidelines. 


LUGPA's Actions During the COVID-19 Crisis - Protecting Independent Urology Practice
March 20, 2020 
It is critical that we hear about the magnitude of issues you are facing now with regard to the Coronavirus, so that we can communicate this growing list to the members of Congress. It’s imperative they understand exactly what is at stake. Read more here.


Telehealth Medicare Restrictions Relaxed Due to Coronavirus
March 19, 2020 
The Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074) was signed into law on March 6, 2020. It is a bipartisan bill that includes, among other provisions, waivers to certain telehealth requirements to allow Medicare patients to receive telehealth services at home.
Read more here.


LUGPA Postpones Events through April due to Coronavirus
March 2020 
NOTICE: Due to the Coronavirus Pandemic, LUGPA will postpone all LUGPA in-person events through April. These postponements include the Bladder Cancer Academy in Atlanta, the April Regional Meeting in Miami [now July 10-11] , the April Rising Chief Residents Summit in Miami [now July 10-11] and the April DC Fly-Ins. 
Read more here.


LUGPA announces new Resident Clinical Innovation Award 
March 2020 
The Resident Clinical Innovation Award recognizes and celebrates the innovative clinical work of urology residents and fellows that promotes and has the potential to enhance quality clinical outcomes. The award acknowledges the value of clinical innovation to harness new technologies, access to big data and/or the development of systems of care to prevent, diagnose or treat urological disease and promote urological health. Submit Now! 


LUGPA President Interviewed by Urology Times


LUGPA President Dr. Harris discusses legislative/policy challenges in 2020. Urology Times spoke with Dr. Harris at the 2019 LUGPA annual meeting in Chicago.





Members of Congress Need to Hear from You! 
LUGPA DC Fly-In Dates Announced for 2020

February 18, 2020 
Lawmakers are most responsive when they hear from physicians from their districts and states. That’s why we encourage your group to send a physician and/or senior administrator to Washington, DC to attend our Capitol Hill visits with the LUGPA Political Affairs Committee. 
Read more about the 2020 Fly-In dates.

LUGPA Supports Bipartisan House Bill: the PSA Screening for HIM Act
February 11, 2020 
On February 11, 2020, LUGPA sent a letter to House Representatives Bobby L. Rush and Larry Bucshon in strong support for H.R. 5200, the PSA Screening for High-risk Insured Men (HIM) Act. The letter states, "The PSA Screening for HIM Act is critically important as the number of deaths due to prostate cancer has been increasing – prostate cancer is now the second highest cancer-related cause of death in the United States. Tragically, many of these lives would not have been lost had the cancer been detected early. The goal of your legislation is laudable as it will increase access to prostate cancer screenings by eliminating cost-sharing requirements to patients."   

LUGPA Escalates its Fight for Site-Neutral Payments
February 5, 2020 
Continuing our ongoing efforts as advocates for site-neutral payments, the LUGPA Board approved the development of an amicus curiae brief in support of the HHS Secretary’s action to cap rates for hospital clinic visit services in the off-campus outpatient department setting. To read more, click here.   

Report of the Advanced Prostate Cancer Consensus Conference 2019

January 28, 2020 
Innovations in treatments, imaging, and molecular characterization in advanced prostate cancer have improved outcomes, but there are still many aspects of management that lack high-level evidence to inform clinical practice. The Advanced Prostate Cancer Consensus Conference (APCCC) 2019 addressed some of these topics to supplement guidelines that are based on level 1 evidence.  To read more, click here.
  
 

Comment Letters Recently Submitted

January 1, 2020 
On December 31, 2019, LUGPA sent comment letters to the Department of Health and Human Services and the Centers for Medicare & Medicaid Services regarding 
the Anti-Kickback Statute Proposed Rule and the Stark Proposed Rule (respectively).  To read these letters and learn more about LUGPA's stance on these issues, click here .   


LUGPA 2019 Annual Meeting Recap
December 18, 2019
From start to finish of our three-day meeting, we saw the exchange of ideas, heard valuable insights and discussed solutions to enhance, improve and grow our individual groups. To see photos from the meeting and read a recap of all the meeting highlights, click here.


AUDIO Interview: Dr. Shore Discusses the article "Preserving Independent Urology: LUGPA’s First Decade"
December 18, 2019
Neal D. Shore, MD and E. David Crawford, MD, discuss the Reviews in Urology article (excerpted and linked below) and the ways in which LUGPA has advocated on behalf of community urology physicians and patients over the last ten years.

Preserving Independent Urology: LUGPA’s First Decade
December 2, 2019
Recently published in Reviews in Urology, this article is an encompassing overview of LUGPA's origins and evolution over the past ten years.

Jeb Bush Discusses Politics and More at LUGPA

November 9, 2019 
A comprehensive rundown of Jeb Bush's keynote address and Q&A session at the 2019 LUGPA Annual Meeting was covered in renalandurologynews.com. Check it out here. More coverage of the 2019 LUGPA Annual Meeting can be found here.  


LUGPA Reappoints Three Members to Board of Directors
November 8, 2019
LUGPA announced today the reappointment of three members to the 2020 Board of Directors at the 2019 Annual Meeting held November 7-9 in Chicago.

E. Scot Davis is Elected to LUGPA Board of Directors
November 8, 2019
E. Scot Davis, CEO of Arkansas Urology, was elected to LUGPA’s Board of Directors at the 2019 Annual Meeting held on November 7-9 in Chicago. 

Urology Groups: 340B Program Reform Needed
October 18, 2019
A new study by the Partnership for Health Analytic Research (PHAR) appears to bolster arguments by independent physicians and those who operate outpatient clinics that they are at a substantial financial disadvantage against hospitals when it comes retaining profits from the administration of injectable and infused drugs. [...]

Profit Disparity Between Hospitals, Independent Practices Has 'Catastrophic Implications' — 3 Thoughts from Dr. Mara Holton
October 2, 2019
Independent practices retained 9 percent of profits from physician-administered medicines, with hospitals retaining the other 91 percent, according to the Partnership for Health Analytic Research's new Hospital Margin Analysis Report. Mara Holton, MD, discussed the findings with Becker's ASC Review. Dr. Holton is an independent physician and vice chair of the health policy committee for LUGPA, the Large Urology Group Practice Association. [...]

Hospitals Retain 91% of Profit from Physician-Administered Drugs
September 17, 2019
Hospital keep a greater share of the gross profit margin on physician-administered drugs, indicating a need to level the playing field for physician practices, according to some experts. [...]

Hospitals Drive More Costs, Get Less Scrutiny
September 11, 2019
After a six-week recess (ahem, “district work period”), Congress is finally reconvening to commence work on drug-pricing legislation. A combination of populist ire over rising out-of-pocket drug costs and left-wing antipathy for for-profit healthcare has fueled legislation that would fundamentally rewrite the Medicare and Medicaid prescription drug programs. [...]

3 ASC Price Transparency Insights
September 10, 2019
Three ASC industry experts shared their insights on price transparency with Becker's ASC Review. [...]

How Benchmarking Helps Manage Your Time, Identify Problem Areas
August 22, 2019
LUGPA recently teamed with IntrinsiQ Specialty Solutions (IQSS), part of AmerisourceBergen, to support a new benchmarking program powered by InfoDive, IQSS’s business analytics solution. This collaboration, LUGPA says, will allow LUGPA member practices to compare independent group practice performance metrics against that of other member practices. [...]

How a 70-Physician Specialty Practice Centralized RCM Processes — 5 Insights 
August 07, 2019 

Maryanne Thompson is the controller for MidLantic Urology, a specialty practice with 46 locations and 70-plus physicians in the U.S. Ms. Thompson told Becker's ASC Review about MidLantic Urology's biggest revenue cycle management problem and how AI helped solve it. [...]

AAOS Will Be 'Closely Evaluating' How Trump's Executive Order Affects Orthopedics 
July 17, 2019 
In late June, President Donald Trump issued an executive order intended to lower costs and help patients make informed decisions by increasing price transparency in healthcare. The decree elicited a cautiously optimistic response from the American Association of Orthopaedic Surgeons, which provides musculoskeletal education to more than 38,000 orthopedic surgeons around the world. [...]

CMS Proposed Rule on Bundled Payment for Radiation Therapy Services
July 16, 2019
On July 10th CMS released the proposed rule regarding the bundled payment for radiation therapy services. The development of a radiation oncology APM was stipulated in the payment freeze passed by Congress; for some time LUGPA has been engaged with CMS and other stakeholders to ensure that integrated urology practices were not excluded from participation. […]

New Study Shows Americans Are Concerned About How Hospital Mergers and Acquisitions Will Impact Their Care
December 7, 2018
CHICAGO, IL, December 3, 2018 – LUGPA, today released a new national survey of 1,191 adults that revealed more than sixty percent of adult Americans are concerned about the impact of hospital mergers and acquisitions on their access to affordable care, with 25 percent reporting that this increasing trend is a threat to their health. […]

LUGPA to Testify at Stark Law Hearing in Support of Modernization
July 17, 2018
WASHINGTON, DC, July 17, 2018 – Appearing today at a hearing of the United States House of Representatives’ Ways and Means Committee entitled, “Modernizing Stark Law to Ensure the Successful Transition from Volume to Value in the Medicare Program,” LUGPA’s Past President and Advanced Payment Model Task Force Chair, Gary Kirsh, MD, testified on the […]

LUGPA Supports CMS’ Efforts to Modernize Stark Law
June 22, 2018
On June 20, 2018, The Centers for Medicare & Medicaid Services (CMS) issued a request for public comment on how to address the regulatory impact and burden of the physician self-referral law known as Stark Law. LUGPA issued the following statement. LUGPA commends CMS for its efforts to address the barriers created by outdated Stark […]

LUGPA statement on UPSPTF Recommendations
May 9, 2018
On May 8, the United States Preventive Services Task Force (USPSTF) posted its Prostate Cancer Screening final recommendations. https://screeningforprostatecancer.org/ LUGPA recognizes the decision by USPSTF to finalize its preliminary Grade “C” recommendation for PSA screening of men aged 55-69 is an improvement over its 2012 one-size-fits-all recommendation against PSA-based screening for any man. Yet, our […]

Proposed Certificate of Need Effort in Michigan Defeated
March 29, 2018
Urologists Mobilized to Defeat Threat to Independent Practices Chicago, IL, March 27, 2018 – In the wake of a successful coordinated effort by LUGPA and its Michigan-based member practices and in conjunction with other health care providers to defeat a proposed Certificate of Need requirement for […]

LUGPA Endorses AACU Policy Statement on Genomic Testing
March 12, 2018
Chicago, March 7, 2018—The National Comprehensive Cancer Network (NCCN) guidelines for Prostate Cancer version 1.2018, incorporate a position statement on genomic testing in prostate cancer. The position statement was proposed by the American Association of Clinical Urologists (AACU) and endorsed by LUGPA. The following statement can be […]

Budget Proposal Focuses Discussion of Physician Self-Referral Reform
February 19, 2018
New Budget Encourages Participation in APMs Chicago, IL, February 16, 2018 – Earlier this week, President Trump released a proposed budget for 2019, which included several proposals that impact independent physician practices. Two of the outlined proposals will directly impact LUGPA practices: the first proposal eliminates the […]

Healthcare Funding Addressed in Congressional Budget Resolution
February 9, 2018
LUGPA Sees Opportunity for Independent Practices Under New Healthcare Policies Chicago, IL, February 9, 2018 – Today, the United States Congress passed a major budget resolution to fund the government, which included several provisions important to health care providers. LUGPA has been a vocal champion for […]

LUGPA Supports Government’s Efforts to Modernize Stark Law
January 25, 2018
LUGPA Supports Government’s Efforts to Modernize Stark Law New Task Force Announced by Federal Government Recognizes a Glaring Need Chicago, IL, January 22, 2018–On January 17, 2018, CMS Administrator Seema Verma announced that The Centers for Medicare & Medicaid Services (CMS) will form an interagency group to review the regulatory barriers posed by Stark law. […]